Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald S Anson

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Genetic Vaccines and Therapy|August 18, 2004
The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene deliveryDonald S Anson
Veterinary Immunology and Immunopathology|September 13, 2003
Molecular cloning of feline CD34Gouri Yogalingam, Donald S Anson
Journal of Paediatrics and Child Health|May 11, 2007
Gene therapy for disorders affecting children, progress and potentialDonald S Anson, Janice M Fletcher
BMC Biotechnology|October 9, 2009
Refinement of lentiviral vector for improved RNA processing and reduced rates of self inactivation repairRachel M Koldej, Donald S Anson
The Journal of Gene Medicine|August 5, 2010
Correction of mucopolysaccharidosis type IIIA somatic and central nervous system pathology by lentiviral-mediated gene transferChantelle McIntyre, Sharon Byers, Donald S Anson
Molecular Genetics and Metabolism|September 25, 2010
Comparison of ventricular and intravenous lentiviral-mediated gene therapy for murine MPS VIIJulie Bielicki, Chantelle McIntyre, Donald S Anson
Current Gene Therapy|February 5, 2011
Therapies for neurological disease in the mucopolysaccharidosesDonald S Anson, Chantelle McIntyre, Sharon Byers
Current Gene Therapy|April 14, 2006
Gene therapy for cystic fibrosis airway disease- is clinical success imminent?Donald S Anson, Gregory J Smith, David W Parsons
Human Gene Therapy|November 13, 2002
Recovery of airway cystic fibrosis transmembrane conductance regulator function in mice with cystic fibrosis after single-dose lentivirus-mediated gene transferMaria Limberis, Donald S Anson, Maria Fuller, et al.
Cell Biology International|July 5, 2003
Immortalisation of a mucopolysaccharidosis type IIIC fibroblast cell line via expression of SV40 T antigenKathy Nelson, Elizabeth L Melville, Peter J Meikle, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Genetic Vaccines and Therapy|August 18, 2004
The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene deliveryDonald S Anson
Veterinary Immunology and Immunopathology|September 13, 2003
Molecular cloning of feline CD34Gouri Yogalingam, Donald S Anson
Journal of Paediatrics and Child Health|May 11, 2007
Gene therapy for disorders affecting children, progress and potentialDonald S Anson, Janice M Fletcher
BMC Biotechnology|October 9, 2009
Refinement of lentiviral vector for improved RNA processing and reduced rates of self inactivation repairRachel M Koldej, Donald S Anson
The Journal of Gene Medicine|August 5, 2010
Correction of mucopolysaccharidosis type IIIA somatic and central nervous system pathology by lentiviral-mediated gene transferChantelle McIntyre, Sharon Byers, Donald S Anson
Molecular Genetics and Metabolism|September 25, 2010
Comparison of ventricular and intravenous lentiviral-mediated gene therapy for murine MPS VIIJulie Bielicki, Chantelle McIntyre, Donald S Anson
Current Gene Therapy|February 5, 2011
Therapies for neurological disease in the mucopolysaccharidosesDonald S Anson, Chantelle McIntyre, Sharon Byers
Current Gene Therapy|April 14, 2006
Gene therapy for cystic fibrosis airway disease- is clinical success imminent?Donald S Anson, Gregory J Smith, David W Parsons
Human Gene Therapy|November 13, 2002
Recovery of airway cystic fibrosis transmembrane conductance regulator function in mice with cystic fibrosis after single-dose lentivirus-mediated gene transferMaria Limberis, Donald S Anson, Maria Fuller, et al.
Cell Biology International|July 5, 2003
Immortalisation of a mucopolysaccharidosis type IIIC fibroblast cell line via expression of SV40 T antigenKathy Nelson, Elizabeth L Melville, Peter J Meikle, et al.
Pageof 3